Vimarsana
Biggest News Aggregation in the World

Page 7 - Mike Sinclair News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mike Sinclair. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mike Sinclair Today - Breaking & Trending Today

Huge problem with Dodge Ram, Ford F150 and Toyota Tundra - Vimarsana News

Huge problem with Dodge Ram, Ford F150 and Toyota Tundra

A road safety expert has issued a warning as an influx of US-style pick up trucks rise in popularity across Australia.

Addex Receives Nasdaq Notification Regarding Minimum Bid - Vimarsana News

Addex Receives Nasdaq Notification Regarding Minimum Bid

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, May 18, 2022 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...

RadioMedix and Orano Med Complete Patient Enrolment in Phase II Trial of Targeted Alpha-Emitter AlphaMedix in Neuroendocrine Cancers - Vimarsana News

RadioMedix and Orano Med Complete Patient Enrolment in Phase II Trial of Targeted Alpha-Emitter AlphaMedix in Neuroendocrine Cancers

Trial's Objective Response Rate Endpoint Already Achieved RadioMedix and Orano Med, two clinical stage radiopharmaceutical companies, today announced that the last patient has been dosed in the Phase

Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's - Vimarsana News

Addex Announces ADX71149 Phase 2 Epilepsy Clinical Study's

Cohort 1 progressing through Part 2Cohort 2 recruiting patients Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex...

Addex Therapeutics : Ad Hoc Announcement Pursuant to Art. 53 LR - Form 6-K - Vimarsana News

Addex Therapeutics : Ad Hoc Announcement Pursuant to Art. 53 LR - Form 6-K

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 10, 2023 - Addex Therapeutics , a clinical-stage pharmaceutical company pioneering allosteric... | May 10, 2023